Managing patients with “treatment‐resistant” schizophrenia

Clozapine for the Treatment-Resistant Schizophrenic

1988 • 4,030 citations

Neurocognitive Deficits and Functional Outcome in Schizophrenia: Are We Measuring the "Right Stuff"?

2000 • 2,955 citations

Clozapine Treatment for Suicidality in Schizophrenia<subtitle>International Suicide Prevention Trial (InterSePT)</subtitle>

2003 • 1,290 citations

The Effects of Clozapine, Risperidone, and Olanzapine on Cognitive Function in Schizophrenia

1999 • 1,012 citations

Neurocognitive Effects of Clozapine, Olanzapine, Risperidone, and Haloperidol in Patients With Chronic Schizophrenia or Schizoaffective Disorder

2002 • 536 citations

Myocarditis and cardiomyopathy associated with clozapine

1999 • 522 citations

Abnormalities in Glucose Regulation During Antipsychotic Treatment of Schizophrenia

2002 • 519 citations

Evidence of Clozapine’s Effectiveness in Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Trials

1999 • 357 citations

Psychopharmacologic Treatment of Schizophrenia

1993 • 283 citations

Risperidone Versus Clozapine in Treatment-Resistant Chronic Schizophrenia: A Randomized Double-Blind Study

1998 • 277 citations

Evaluation of Treatment-Resistant Schizophrenia

1997 • 241 citations

Olanzapine Compared With Chlorpromazine in Treatment-Resistant Schizophrenia

1998 • 239 citations

Double-blind comparison of olanzapine versus clozapine in schizophrenic patients clinically eligible for treatment with clozapine

2001 • 192 citations

Schizophrenia : a neuropsychological perspective

1996 • 181 citations

Medical comorbidity in schizophrenia

2003 • 140 citations

Comparative efficacy of olanzapine and haloperidol for patients with treatment-resistant schizophrenia∗∗See accompanying Editorial, in this issue.

1999 • 126 citations

Treatment-resistant schizophrenic patients respond to clozapine after olanzapine non-response

1999 • 123 citations

Treatment-resistant schizophrenic patients.

1996 • 115 citations

One-year, low-dose neuroleptic study of in-patients with chronic schizophrenia characterised by persistent negative symptoms

1997 • 102 citations

Review of atypical antipsychotics and weight gain.

2001 • 99 citations

Treatment Outcomes in Schizophrenia: Implications for Practice, Policy, and Research

1995 • 99 citations

Spatial Working Memory Deficits in Schizophrenia: Relationship With Tardive Dyskinesia and Negative Symptoms

2001 • 92 citations

Quality of Life and New Antipsychotics in Schizophrenia Are Patients Better Off?

1999 • 79 citations

Incidental radiological findings on brain magnetic resonance imaging in first‐episode psychosis and chronic schizophrenia

2002 • 77 citations

Psychotic disorders in urban areas: an overview of the Study on Low Prevalence Disorders

2000 • 67 citations

Drug Strategies and Treatment-Resistant Schizophrenia

1996 • 66 citations

The evolving definition of treatment resistance.

1999 • 65 citations

Short-Term Effect of Combined ECT and Neuroleptic Therapy in Treatment-Resistant Schizophrenia

1999 • 61 citations

Clozapine treatment in Australia: a review of haematological monitoring

1998 • 58 citations

The Australian National Survey of Psychotic Disorders: profile of psychosocial disability and its risk factors

2002 • 54 citations

Management strategies for the treatment of schizophrenia.

1999 • 52 citations

Management of Treatment Resistant Schizophrenia Unresponsive to Clozapine

1996 • 48 citations

A Conceptual Review of Functioning: Implications for the Development of Consumer Outcome Measures

2001 • 46 citations

Four Behavioural Syndromes of Schizophrenia

1996 • 40 citations

Pharmacological approaches to the management of schizophrenia

2003 • 40 citations

A meaningful day: integrating psychosocial rehabilitation into community treatment of schizophrenia

2003 • 29 citations

Deleted Work

1955 • 0 citations